World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management

J Gotlib - American journal of hematology, 2015 - Wiley Online Library
Disease overview: The eosinophilias encompass a broad range of non‐hematologic
(secondary or reactive) and hematologic (primary, clonal) disorders with potential for end …

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise …

SA Wang, W Tam, AG Tsai, DA Arber… - Modern …, 2016 - nature.com
The distinction between chronic eosinophilic leukemia, not otherwise specified and
idiopathic hypereosinophilic syndrome largely relies on clonality assessment. Prior to the …

Genetic landscape of myeloproliferative neoplasms with an emphasis on molecular diagnostic laboratory testing

A Easwar, AJ Siddon - Life, 2021 - mdpi.com
Chronic myeloproliferative neoplasms (MPNs) are hematopoietic stem cell neoplasms with
driver events including the BCR-ABL1 translocation leading to a diagnosis of chronic …

Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma

RC Arend, AI Londoño, AM Montgomery… - Molecular Cancer …, 2018 - aacrjournals.org
While high-grade serous ovarian carcinoma (HGSOC) is the most common histologic
subtype of ovarian cancer, significant tumor heterogeneity exists. In addition, chemotherapy …

Triple-negative essential thrombocythemia: clinical-pathological and molecular features. A single-center cohort study

D Cattaneo, GA Croci, C Bucelli, S Tabano… - Frontiers in …, 2021 - frontiersin.org
Lack of demonstrable mutations affecting JAK2, CALR, or MPL driver genes within the
spectrum of BCR-ABL1-negative myeloproliferative neoplasms (MPNs) is currently referred …

Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids

W Gu, E Talevich, E Hsu, Z Qi, A Urisman… - Genome medicine, 2021 - Springer
Background Metagenomic next-generation sequencing (mNGS) of body fluids is an
emerging approach to identify occult pathogens in undiagnosed patients. We hypothesized …

The KDR (VEGFR-2) genetic polymorphism Q472H and c-KIT polymorphism M541L are associated with more aggressive behaviour in astrocytic gliomas

N Zaman, SS Dass, P Du Parcq… - Cancer Genomics & …, 2020 - cgp.iiarjournals.org
Background/Aim: Better diagnostic and prognostic markers are required for a more accurate
diagnosis and an earlier detection of glioma progression and for suggesting better treatment …

Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer

ML Iacono, C Buttigliero, V Monica, E Bollito… - …, 2016 - pmc.ncbi.nlm.nih.gov
Purpose Prostate cancer (PCa) has a highly heterogeneous outcome. Beyond Gleason
Score, Prostate Serum Antigen and tumor stage, nowadays there are no biological …

Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases

D Cattaneo, A Marchetti, C Bucelli, N Galli… - Clinical and …, 2024 - Springer
Here, we reviewed clinical-morphological data and investigated mutational profiles by NGS
in a single-center series of 28 consecutive patients admitted to our hospital between …

Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?

A Iurlo, D Cattaneo - Blood Reviews, 2023 - Elsevier
Hypereosinophilic syndromes (HES) encompass a wide range of disorders characterized by
persistent peripheral blood hypereosinophilia (HE)(ie, an eosinophil count≥ 1.5× 10 9/L …